The clinical benefits of denosumab for prophylaxis of steroid-induced osteoporosis in patients with pulmonary disease. [electronic resource]
Producer: 20170608Description: 44 p. digitalISSN:- 1862-3514
- Aged
- Aged, 80 and over
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Denosumab -- administration & dosage
- Diphosphonates -- administration & dosage
- Female
- Follow-Up Studies
- Glucocorticoids -- adverse effects
- Humans
- Lumbar Vertebrae -- drug effects
- Lung Diseases -- drug therapy
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Prospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.